SYENSQO SA (SYENS.BR) Fundamental Analysis & Valuation

EBR:SYENSBE0974464977

Current stock price

51.3 EUR
+0.95 (+1.89%)
Last:

This SYENS.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. SYENS.BR Profitability Analysis

1.1 Basic Checks

  • In the past year SYENS was profitable.
  • SYENS had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: SYENS reported negative net income in multiple years.
  • In the past 5 years SYENS always reported a positive cash flow from operatings.
SYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFSYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B

1.2 Ratios

  • SYENS has a Return On Assets of -0.54%. This is comparable to the rest of the industry: SYENS outperforms 42.03% of its industry peers.
  • SYENS's Return On Equity of -1.02% is in line compared to the rest of the industry. SYENS outperforms 42.03% of its industry peers.
  • SYENS has a Return On Invested Capital (3.87%) which is in line with its industry peers.
  • SYENS had an Average Return On Invested Capital over the past 3 years of 5.52%. This is in line with the industry average of 7.00%.
Industry RankSector Rank
ROA -0.54%
ROE -1.02%
ROIC 3.87%
ROA(3y)0.31%
ROA(5y)2.28%
ROE(3y)0.49%
ROE(5y)6.21%
ROIC(3y)5.52%
ROIC(5y)7.32%
SYENS.BR Yearly ROA, ROE, ROICSYENS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

  • The Operating Margin of SYENS (8.18%) is comparable to the rest of the industry.
  • SYENS's Operating Margin has been stable in the last couple of years.
  • The Gross Margin of SYENS (30.23%) is comparable to the rest of the industry.
  • SYENS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.18%
PM (TTM) N/A
GM 30.23%
OM growth 3Y-20.26%
OM growth 5Y-0.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.19%
GM growth 5Y1.3%
SYENS.BR Yearly Profit, Operating, Gross MarginsSYENS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 30

5

2. SYENS.BR Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SYENS is destroying value.
  • The number of shares outstanding for SYENS has been reduced compared to 1 year ago.
  • SYENS has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, SYENS has a worse debt to assets ratio.
SYENS.BR Yearly Shares OutstandingSYENS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
SYENS.BR Yearly Total Debt VS Total AssetsSYENS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • SYENS has an Altman-Z score of 1.99. This is not the best score and indicates that SYENS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • SYENS has a Altman-Z score (1.99) which is in line with its industry peers.
  • SYENS has a debt to FCF ratio of 12.87. This is a negative value and a sign of low solvency as SYENS would need 12.87 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 12.87, SYENS is in line with its industry, outperforming 49.28% of the companies in the same industry.
  • SYENS has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.47, SYENS is in line with its industry, outperforming 49.28% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 12.87
Altman-Z 1.99
ROIC/WACC0.57
WACC6.77%
SYENS.BR Yearly LT Debt VS Equity VS FCFSYENS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • SYENS has a Current Ratio of 2.09. This indicates that SYENS is financially healthy and has no problem in meeting its short term obligations.
  • SYENS's Current ratio of 2.09 is fine compared to the rest of the industry. SYENS outperforms 66.67% of its industry peers.
  • SYENS has a Quick Ratio of 1.41. This is a normal value and indicates that SYENS is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of SYENS (1.41) is better than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.09
Quick Ratio 1.41
SYENS.BR Yearly Current Assets VS Current LiabilitesSYENS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

3

3. SYENS.BR Growth Analysis

3.1 Past

  • SYENS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -46.49%.
  • Looking at the last year, SYENS shows a decrease in Revenue. The Revenue has decreased by -8.56% in the last year.
  • The Revenue has been growing slightly by 2.10% on average over the past years.
EPS 1Y (TTM)-46.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-58.9%
Revenue 1Y (TTM)-8.56%
Revenue growth 3Y-9.76%
Revenue growth 5Y2.1%
Sales Q2Q%-11.26%

3.2 Future

  • The Earnings Per Share is expected to grow by 19.42% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 2.20% on average over the next years.
EPS Next Y68.48%
EPS Next 2Y39.73%
EPS Next 3Y25.76%
EPS Next 5Y19.42%
Revenue Next Year-6.24%
Revenue Next 2Y-1.14%
Revenue Next 3Y0.43%
Revenue Next 5Y2.2%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SYENS.BR Yearly Revenue VS EstimatesSYENS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
SYENS.BR Yearly EPS VS EstimatesSYENS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

7

4. SYENS.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 18.19, which indicates a rather expensive current valuation of SYENS.
  • 69.57% of the companies in the same industry are more expensive than SYENS, based on the Price/Earnings ratio.
  • SYENS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.91.
  • SYENS is valuated reasonably with a Price/Forward Earnings ratio of 10.80.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SYENS indicates a rather cheap valuation: SYENS is cheaper than 91.30% of the companies listed in the same industry.
  • SYENS is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.19
Fwd PE 10.8
SYENS.BR Price Earnings VS Forward Price EarningsSYENS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SYENS indicates a rather cheap valuation: SYENS is cheaper than 86.96% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, SYENS is valued a bit cheaper than the industry average as 62.32% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 23.18
EV/EBITDA 5.95
SYENS.BR Per share dataSYENS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as SYENS's earnings are expected to grow with 25.76% in the coming years.
PEG (NY)0.27
PEG (5Y)N/A
EPS Next 2Y39.73%
EPS Next 3Y25.76%

2

5. SYENS.BR Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.31%, SYENS has a reasonable but not impressive dividend return.
  • In the last 3 months the price of SYENS has falen by -29.08%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 2.35, SYENS has a dividend in line with its industry peers.
  • SYENS's Dividend Yield is a higher than the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 2.31%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
SYENS.BR Yearly Dividends per shareSYENS.BR Yearly Dividends per shareYearly Dividends per share 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • SYENS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-267.74%
EPS Next 2Y39.73%
EPS Next 3Y25.76%
SYENS.BR Yearly Income VS Free CF VS DividendSYENS.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

SYENS.BR Fundamentals: All Metrics, Ratios and Statistics

SYENSQO SA

EBR:SYENS (4/9/2026, 5:36:17 PM)

51.3

+0.95 (+1.89%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-26
Earnings (Next)05-15
Inst Owners34.63%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.33B
Revenue(TTM)6.26B
Net Income(TTM)-62.00M
Analysts75.71
Price Target68.1 (32.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.31%
Yearly Dividend1.62
Dividend Growth(5Y)N/A
DP-267.74%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-39.02%
Min EPS beat(2)-62.91%
Max EPS beat(2)-15.13%
EPS beat(4)0
Avg EPS beat(4)-35.47%
Min EPS beat(4)-62.91%
Max EPS beat(4)-4.8%
EPS beat(8)1
Avg EPS beat(8)-22.08%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.31%
Min Revenue beat(2)-8.28%
Max Revenue beat(2)-4.35%
Revenue beat(4)0
Avg Revenue beat(4)-4.86%
Min Revenue beat(4)-8.28%
Max Revenue beat(4)-2.18%
Revenue beat(8)0
Avg Revenue beat(8)-4.18%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-16.57%
PT rev (3m)-16.17%
EPS NQ rev (1m)-40.89%
EPS NQ rev (3m)-53.27%
EPS NY rev (1m)-9.73%
EPS NY rev (3m)-12.19%
Revenue NQ rev (1m)-11.93%
Revenue NQ rev (3m)-14.68%
Revenue NY rev (1m)-5.32%
Revenue NY rev (3m)-7%
Valuation
Industry RankSector Rank
PE 18.19
Fwd PE 10.8
P/S 0.85
P/FCF 23.18
P/OCF 6.96
P/B 0.88
P/tB 2.42
EV/EBITDA 5.95
EPS(TTM)2.82
EY5.5%
EPS(NY)4.75
Fwd EY9.26%
FCF(TTM)2.21
FCFY4.31%
OCF(TTM)7.37
OCFY14.37%
SpS60.23
BVpS58.25
TBVpS21.22
PEG (NY)0.27
PEG (5Y)N/A
Graham Number60.79
Profitability
Industry RankSector Rank
ROA -0.54%
ROE -1.02%
ROCE 5.16%
ROIC 3.87%
ROICexc 4.27%
ROICexgc 7.46%
OM 8.18%
PM (TTM) N/A
GM 30.23%
FCFM 3.67%
ROA(3y)0.31%
ROA(5y)2.28%
ROE(3y)0.49%
ROE(5y)6.21%
ROIC(3y)5.52%
ROIC(5y)7.32%
ROICexc(3y)6.1%
ROICexc(5y)7.8%
ROICexgc(3y)10.76%
ROICexgc(5y)16.74%
ROCE(3y)7.36%
ROCE(5y)9.75%
ROICexgc growth 3Y-39.16%
ROICexgc growth 5Y-16.84%
ROICexc growth 3Y-31.97%
ROICexc growth 5Y-5.73%
OM growth 3Y-20.26%
OM growth 5Y-0.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.19%
GM growth 5Y1.3%
F-Score4
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 12.87
Debt/EBITDA 2.37
Cap/Depr 77.23%
Cap/Sales 8.56%
Interest Coverage 250
Cash Conversion 63.52%
Profit Quality N/A
Current Ratio 2.09
Quick Ratio 1.41
Altman-Z 1.99
F-Score4
WACC6.77%
ROIC/WACC0.57
Cap/Depr(3y)92.5%
Cap/Depr(5y)88.2%
Cap/Sales(3y)10.04%
Cap/Sales(5y)8.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-58.9%
EPS Next Y68.48%
EPS Next 2Y39.73%
EPS Next 3Y25.76%
EPS Next 5Y19.42%
Revenue 1Y (TTM)-8.56%
Revenue growth 3Y-9.76%
Revenue growth 5Y2.1%
Sales Q2Q%-11.26%
Revenue Next Year-6.24%
Revenue Next 2Y-1.14%
Revenue Next 3Y0.43%
Revenue Next 5Y2.2%
EBIT growth 1Y-19.87%
EBIT growth 3Y-28.04%
EBIT growth 5Y1.26%
EBIT Next Year77.59%
EBIT Next 3Y24.51%
EBIT Next 5Y18.31%
FCF growth 1Y5.99%
FCF growth 3Y-32.41%
FCF growth 5Y-21.57%
OCF growth 1Y-8.92%
OCF growth 3Y-16.92%
OCF growth 5Y-6.85%

SYENSQO SA / SYENS.BR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SYENSQO SA (SYENS.BR) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SYENS.BR.


Can you provide the valuation status for SYENSQO SA?

ChartMill assigns a valuation rating of 7 / 10 to SYENSQO SA (SYENS.BR). This can be considered as Undervalued.


How profitable is SYENSQO SA (SYENS.BR) stock?

SYENSQO SA (SYENS.BR) has a profitability rating of 4 / 10.


What are the PE and PB ratios of SYENSQO SA (SYENS.BR) stock?

The Price/Earnings (PE) ratio for SYENSQO SA (SYENS.BR) is 18.19 and the Price/Book (PB) ratio is 0.88.


Can you provide the dividend sustainability for SYENS stock?

The dividend rating of SYENSQO SA (SYENS.BR) is 2 / 10 and the dividend payout ratio is -267.74%.